Metal-organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances,

Ziliang Guo1, Yuzhen Xiao2, Wenting Wu3

  • 1Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.

PubMed

Insights

Metal-organic frameworks (MOFs) are advanced materials for stimuli-responsive drug delivery systems (SRDDSs) in cancer therapy. This review explores MOF-based SRDDSs, their mechanisms, and future clinical translation potential.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Oncology

Background:

  • Cancer treatment demands precise drug delivery to enhance efficacy and minimize side effects.
  • Stimuli-responsive drug delivery systems (SRDDSs) offer targeted therapeutic approaches.
  • Metal-organic frameworks (MOFs) present unique properties for advanced drug delivery applications.

Purpose of the Study:

  • To review the application of MOF-based SRDDSs in diverse cancer therapy modalities.
  • To summarize the synthesis, modification, and stimuli-responsive mechanisms of MOF-based SRDDSs.
  • To discuss challenges and future directions, including AI in MOF synthesis for improved cancer treatment.

Main Methods:

  • Literature review of MOF-based SRDDSs in cancer therapy.
  • Analysis of stimuli-responsive mechanisms (endogenous and exogenous).
  • Exploration of MOF synthesis, modification, and drug loading strategies.

Main Results:

  • MOFs are versatile platforms for constructing SRDDSs due to their tunable properties.
  • MOF-based SRDDSs effectively target tumors and respond to various stimuli for controlled drug release.
  • Applications span chemotherapy, radiotherapy, photothermal, and photodynamic cancer therapies.

Conclusions:

  • MOF-based SRDDSs show significant promise for advanced cancer treatment.
  • Addressing current challenges and integrating AI can accelerate the clinical translation of these systems.
  • Further research is needed to optimize efficacy and safety for patient benefit.

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery Systems: Different Types01:27

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...